• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Quanttus pulls in a $19M Series A round for wearable vital signs monitor

Quanttus pulls in a $19M Series A round for wearable vital signs monitor

February 26, 2014 By Brad Perriello

Quanttus lands $19M in funding

Cambridge, Mass.-based Quanttus said it brought in $19 million in a Series A funding round from Khosla Ventures and Matrix Partners, following a $3 million seed round from Khosla founder Vinod Khosla.

MIT spinout Quanttus is developing a wearable vital signs monitor designed to measure heart rate, respiration and blood pressure that resembles a wristwatch, according to the MIT Technology Review.

The seed and Series A cash are slated for Quanttus’ work on "breakthroughs in clinical-grade vital signs monitoring and advances in contextual analysis to create wearable technologies that, for the first time, help people proactively understand their bodies and improve their health," according to a press release.

The device, developed by a Dream Team including members from MIT, Nike (NYSE:NKE), Apple (NSDQ:AAPL), Ideo and Mass. General Hospital, the Quanttus system consists of a wearable device designed to capture more than 500,000 vital sign data points each day plus software designed to "translate this data into real-time insights to help people make choices that improve their health," Quanttus said.

"We’re building, basically, a hardware platform; a wearable that sits on your wrist,” Quanttus co-founder & CEO Shahid Azim told the MIT Technology Review recently. “But then there’s an equally large effort around how to make sense, how to generate insights, from this data."

Quanttus has been running validation study at Mass. General since September 2013, aiming to compare its prototype with standard methods for collecting heart rate, respiration and BP data from patients, according to the review. Azim called the early results "very promising," predicting a beta version for app developers early this year, the review reported.

“You’d need at least 3 to 5 different devices today to do all the things we’re doing, which makes it very unique,” Azim told the Boston Business Journal after the Series A round was announced. “We’re not interested in building another Fitbit. … we’re really getting to relevant data, that’s beyond just counting steps and calories.”

Christopher Walker contributed to this report.

Filed Under: Digital Health, Funding Roundup, News Well, Patient Monitoring Tagged With: Khosla Ventures, Mass. Institute of Technology, Matrix Partners, Quanttus

More recent news

  • Cognixion, Blackrock Neurotech ink distro deal for BCI tech
  • AdvaMed calls for medtech tariff exemptions at Senate hearing
  • GE HealthCare, Raydiant Oximetry partner on fetal oxygen saturation tech
  • Terumo Neuro launches new stroke catheter in the U.S.
  • EnVVeno has first-in-human heart valve data, expects FDA decision this year

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy